probenecid has been researched along with Respiratory Syncytial Virus Infections in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, J | 1 |
| Bergeron, HC | 1 |
| Jones, LP | 1 |
| Reener, ZB | 1 |
| Martin, DE | 1 |
| Sancilio, FD | 1 |
| Tripp, RA | 1 |
1 other study available for probenecid and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication.
Topics: Animals; COVID-19; Mice; Probenecid; Respiratory Syncytial Virus Infections; Respiratory Syncytial V | 2022 |